25021-247 : Cyclophosphamide 500 mg/25ml Intravenous Injection, Powder, Lyophilized, for Solution


NDC: 25021-247
Labeler: Sagent Pharmaceuticals
Product Type: Human Prescription Drug
Drug Name:  Cyclophosphamide
Dosage Form: Intravenous Injection, Powder, Lyophilized, for Solution
Application #: ANDA214529
Rev. Date: 


NDC Package Codes:

  • 25021-247-50: 1 VIAL IN 1 CARTON (25021‑247‑50) / 25 ML IN 1 VIAL

Active Ingredients:

  • Cyclophosphamide

Dosage Strength:

  • 500 mg/25mL

Pharmaceutical Classes:

  • Alkylating Activity [MoA]
  • Alkylating Drug [EPC]

Related Products:

Based on records with the same trade name.
  • 25021-248 Cyclophosphamide 1 g/50ml Intravenous Injection, Powder, Lyophilized, for Solution by Sagent Pharmaceuticals
  • 25021-249 Cyclophosphamide 2 g/100ml Intravenous Injection, Powder, Lyophilized, for Solution by Sagent Pharmaceuticals
  • 0054-0382 Cyclophosphamide 25 mg Oral Capsule by Roxane Laboratories, Inc.
  • 0054-0383 Cyclophosphamide 50 mg Oral Capsule by Roxane Laboratories, Inc.
  • 0054-4129 Cyclophosphamide 25 mg Oral Tablet by Roxane Laboratories, Inc
  • 0054-4130 Cyclophosphamide 50 mg Oral Tablet by Roxane Laboratories, Inc
  • 0781-3233 Cyclophosphamide 500 mg/25ml Intravenous; Oral Injection, Powder, for Solution by Sandoz Inc.
  • 0781-3244 Cyclophosphamide 1 g/50ml Intravenous; Oral Injection, Powder, for Solution by Sandoz Inc.
  • 0781-3255 Cyclophosphamide 2 g/100ml Intravenous; Oral Injection, Powder, for Solution by Sandoz Inc.
  • 10019-935 Cyclophosphamide 500 mg/25ml Intravenous; Oral Injection, Powder, for Solution by Baxter Healthcare Corporation
  • 10019-936 Cyclophosphamide 1 g/50ml Intravenous; Oral Injection, Powder, for Solution by Baxter Healthcare Corporation
  • 10019-937 Cyclophosphamide 2 g/100ml Intravenous; Oral Injection, Powder, for Solution by Baxter Healthcare Corporation
  • 10019-938 Cyclophosphamide 500 mg/25ml Intravenous; Oral Injection, Powder, for Solution by Baxter Healthcare Corporation
  • 10019-939 Cyclophosphamide 1 g/50ml Intravenous; Oral Injection, Powder, for Solution by Baxter Healthcare Corporation
  • 10019-942 Cyclophosphamide 2 g/100ml Intravenous; Oral Injection, Powder, for Solution by Baxter Healthcare Corporation
  • 10019-943 Cyclophosphamide 500 mg/25ml Intravenous; Oral Injection, Powder, for Solution by Baxter Healthcare Corporation
  • 10019-944 Cyclophosphamide 1 g/50ml Intravenous; Oral Injection, Powder, for Solution by Baxter Healthcare Corporation
  • 10019-945 Cyclophosphamide 2 g/100ml Intravenous; Oral Injection, Powder, for Solution by Baxter Healthcare Corporation
  • 10019-955 Cyclophosphamide 500 mg/25ml Intravenous; Oral Injection, Powder, for Solution by Baxter Healthcare Corporation
  • 10019-956 Cyclophosphamide 1 g/50ml Intravenous; Oral Injection, Powder, for Solution by Baxter Healthcare Corporation
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 25021-247 QR Code

< Prev: 25021-246Next: 25021-248 >

Related Discussions:

greyhound cyclophosphamide with pirixicam cyl hycl 100 cap
My Greyhound Cut his Foot And He Takes Cyclophosphamide 17 Mg With Pirixicam 11 mg once A Day with food. I Want To Know ...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.